Title |
Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension
|
---|---|
Published in |
Cochrane database of systematic reviews, January 2010
|
DOI | 10.1002/14651858.cd007185.pub2 |
Pubmed ID | |
Authors |
Jenny MH Chen, Balraj S Heran, Marco I Perez, James M Wright |
Abstract |
Beta-blockers are one of the more commonly prescribed classes of anti-hypertensive drugs, both as first-line and second-line. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 33% |
Unknown | 2 | 67% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 92 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Japan | 1 | 1% |
United Kingdom | 1 | 1% |
Colombia | 1 | 1% |
Unknown | 89 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 13 | 14% |
Student > Master | 12 | 13% |
Researcher | 10 | 11% |
Student > Ph. D. Student | 8 | 9% |
Student > Postgraduate | 6 | 7% |
Other | 18 | 20% |
Unknown | 25 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 43 | 47% |
Nursing and Health Professions | 6 | 7% |
Agricultural and Biological Sciences | 4 | 4% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Other | 5 | 5% |
Unknown | 29 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 December 2020.
All research outputs
#6,392,102
of 23,577,761 outputs
Outputs from Cochrane database of systematic reviews
#8,269
of 12,746 outputs
Outputs of similar age
#40,945
of 167,209 outputs
Outputs of similar age from Cochrane database of systematic reviews
#59
of 120 outputs
Altmetric has tracked 23,577,761 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 12,746 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 33.1. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 167,209 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.